Initial Statement of Beneficial Ownership

FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Expires: February 28, 2011
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Marstiller Jean W

2. Date of Event Requiring Statement (MM/DD/YYYY)
8/10/2009 

3. Issuer Name and Ticker or Trading Symbol

CUMBERLAND PHARMACEUTICALS INC [CPIX]

(Last)        (First)        (Middle)

2525 WEST END AVE., SUITE 950

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
Sr. VP & Corp. Secretary /

(Street)

NASHVILLE, TN 37203       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   581359   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Options   1/4/2002   1/4/2012   Common Stock   9230   $1.63   D    
Options   1/31/2003   1/31/2013   Common Stock   400   $3.50   D    
Options   4/1/2004   4/1/2014   Common Stock   10000   $6.00   D    
Options   1/15/2005   1/15/2015   Common Stock   3000   $6.00   D    
Options   12/31/2005   1/15/2015   Common Stock   3000   $6.00   D    
Options   12/31/2006   1/15/2015   Common Stock   3000   $6.00   D    
Options   12/31/2006   6/30/2016   Common Stock   2750   $9.00   D    
Options   12/31/2007   1/15/2015   Common Stock   3000   $6.00   D    
Options   12/31/2007   6/30/2016   Common Stock   2750   $9.00   D    
Options   12/31/2007   2/2/2017   Common Stock   3000   $11.00   D    
Options   12/31/2008   1/15/2015   Common Stock   3000   $6.00   D    
Options   12/31/2008   6/30/2016   Common Stock   2750   $9.00   D    
Options   12/31/2008   7/31/2018   Common Stock   2250   $13.00   D    
Options   12/31/2008   2/2/2017   Common Stock   3000   $11.00   D    
Options   12/31/2009   2/2/2017   Common Stock   3000   $11.00   D    
Options   12/31/2009   6/30/2016   Common Stock   2750   $9.00   D    
Options   12/31/2009   7/31/2018   Common Stock   2250   $13.00   D    
Options   12/31/2009   2/16/2019   Common Stock   2250   $13.00   D    
Options   12/31/2010   2/2/2017   Common Stock   3000   $11.00   D    
Options   12/31/2010   7/31/2018   Common Stock   2250   $13.00   D    
Options   12/31/2010   2/16/2019   Common Stock   2250   $13.00   D    
Option   12/31/2011   7/31/2018   Common Stock   2250   $13.00   D    
Options   12/31/2011   2/16/2019   Common Stock   2250   $13.00   D    
Options   12/31/2012   2/16/2019   Common Stock   2250   $13.00   D    

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Marstiller Jean W
2525 WEST END AVE.
SUITE 950
NASHVILLE, TN 37203

Sr. VP & Corp. Secretary

Signatures
Jean W. Marstiller 8/10/2009
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.